Technical Analysis for LPCN - Lipocine Inc.

Grade Last Price % Change Price Change
grade A 1.67 -11.17% -0.21
LPCN closed down 11.17 percent on Friday, January 18, 2019, on 2.94 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical LPCN trend table...

Date Alert Name Type % Chg
Jan 18 Slingshot Bullish Bullish Swing Setup 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Gilligan's Island Sell Setup Bearish Swing Setup -11.17%
Jan 17 New Uptrend Bullish -11.17%
Jan 17 Expansion Breakout Bullish Swing Setup -11.17%
Jan 17 Pocket Pivot Bullish Swing Setup -11.17%
Jan 17 Volume Surge Other -11.17%
Jan 17 Wide Range Bar Range Expansion -11.17%
Jan 17 New 52 Week High Strength -11.17%
Jan 17 Wide Bands Range Expansion -11.17%

Older signals for LPCN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Lipocine Inc., a specialty pharmaceutical company, is engaged in the development of pharmaceutical products in the areas of men's and women's health. The company offers a portfolio of proprietary product candidates that are used to produce pharmacokinetic characteristics; facilitate lower dosing requirements and bypass first-pass metabolism; reduce side effects; and eliminate gastrointestinal interactions that limit bioavailability. Its product candidates for men's health include LPCN 1021, an oral product candidate, which is in Phase III clinical trials; and LPCN 1111, an oral product candidate that is in Phase I/II clinical trials for the treatment of testosterone replacement therapy. The company's product candidates for women's health comprise LPCN 1107, which is in Phase I/II clinical trials for the prevention of preterm birth. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.
Is LPCN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.64
52 Week Low 1.03
Average Volume 629,959
200-Day Moving Average 1.4155
50-Day Moving Average 1.4456
20-Day Moving Average 1.466
10-Day Moving Average 1.626
Average True Range 0.1692
ADX 28.66
+DI 52.2852
-DI 15.8233
Chandelier Exit (Long, 3 ATRs ) 2.1324
Chandelier Exit (Short, 3 ATRs ) 1.5476
Upper Bollinger Band 1.8937
Lower Bollinger Band 1.0383
Percent B (%b) 0.74
BandWidth 58.34925
MACD Line 0.0878
MACD Signal Line 0.0592
MACD Histogram 0.0287
Fundamentals Value
Market Cap 34.37 Million
Num Shares 20.6 Million
EPS -0.93
Price-to-Earnings (P/E) Ratio -1.80
Price-to-Sales 0.00
Price-to-Book 2.86
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.97
Resistance 3 (R3) 1.98 1.89 1.92
Resistance 2 (R2) 1.89 1.81 1.89 1.90
Resistance 1 (R1) 1.78 1.77 1.74 1.77 1.89
Pivot Point 1.69 1.69 1.67 1.69 1.69
Support 1 (S1) 1.58 1.61 1.54 1.57 1.45
Support 2 (S2) 1.49 1.57 1.49 1.44
Support 3 (S3) 1.38 1.49 1.42
Support 4 (S4) 1.37